Premier Research and BioCentriq Enter a Strategic Partnership to Accelerate Pre-IND Timelines and Clinical Translation of Innovative Cell Therapies streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ BioCentriq®, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy launched their new LEAP™.
BioCentriq to Unveil LEAP™ Advanced Therapy Platform During CEO Presentation at the 29th Annual ISCT Annual Event in Paris, France on June 1, 2023 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ BioCentriq, Inc. and panCELLa, a Pluristyx Company, announced that they have signed a research agreement designed to evaluate the ability of.
/PRNewswire/ BioCentriq, Inc. a New Jersey-based, cell and gene therapy contract development and manufacturing organization (CDMO) announced today that.